Literature DB >> 30861547

Epithelial (E)-Cadherin is a Novel Mediator of Platelet Aggregation and Clot Stability.

Vanessa M Scanlon1,2, Alexandra M Teixeira3, Tarun Tyagi4, Siying Zou5, Ping-Xia Zhang1,2, Carmen Jane Booth6, M Anna Kowalska7,8, Jialing Bao9,10,11, John Hwa4, Vincent Hayes12, Michael S Marks9,10,11, Mortimer Poncz11,12, Diane S Krause1,2,3,5.   

Abstract

Cadherins play a major role in mediating cell-cell adhesion, which shares many parallels with platelet-platelet interactions during aggregate formation and clot stabilization. Platelets express epithelial (E)-cadherin, but its contribution to platelet function and/or platelet production is currently unknown. To assess the role of E-cadherin in platelet production and function in vitro and in vivo, we utilized a megakaryocyte-specific E-cadherin knockout mouse model. Loss of E-cadherin in megakaryocytes does not affect megakaryocyte maturation, platelet number or size. However, platelet dysfunction in the absence of E-cadherin is revealed when conditional knockout mice are challenged with acute antibody-mediated platelet depletion. Unlike wild-type mice that recover fully, knockout mice die within 72 hours post-antibody administration, likely from haemorrhage. Furthermore, conditional knockout mice have prolonged tail bleeding times, unstable clot formation, reduced clot retraction and reduced fibrin deposition in in vivo injury models. Murine platelet aggregation in vitro in response to thrombin and thrombin receptor activating peptide is compromised in E-cadherin null platelets, while aggregation in response to adenosine diphosphate (ADP) is not significantly different. Consistent with this, in vitro aggregation of primary human platelets in response to thrombin is decreased by an inhibitory E-cadherin antibody. Integrin activation and granule secretion in response to ADP and thrombin are not affected in E-cadherin null platelets, but Akt and glycogen synthase kinase 3β (GSK3β) activation are attenuated, suggesting a that E-cadherin contributes to aggregation, clot stabilization and retraction that is mediated by phosphoinositide 3-kinase/Akt/GSK3β signalling. In summary, E-cadherin plays a salient role in platelet aggregation and clot stability. Georg Thieme Verlag KG Stuttgart · New York.

Entities:  

Mesh:

Substances:

Year:  2019        PMID: 30861547      PMCID: PMC6599679          DOI: 10.1055/s-0039-1679908

Source DB:  PubMed          Journal:  Thromb Haemost        ISSN: 0340-6245            Impact factor:   5.249


  37 in total

1.  ADP is the cognate ligand for the orphan G protein-coupled receptor SP1999.

Authors:  F L Zhang; L Luo; E Gustafson; J Lachowicz; M Smith; X Qiao; Y H Liu; G Chen; B Pramanik; T M Laz; K Palmer; M Bayne; F J Monsma
Journal:  J Biol Chem       Date:  2000-12-04       Impact factor: 5.157

2.  Persistence of platelet thrombus formation in arterioles of mice lacking both von Willebrand factor and fibrinogen.

Authors:  H Ni; C V Denis; S Subbarao; J L Degen; T N Sato; R O Hynes; D D Wagner
Journal:  J Clin Invest       Date:  2000-08       Impact factor: 14.808

Review 3.  Contact-dependent signaling during the late events of platelet activation.

Authors:  N Prevost; D Woulfe; M Tognolini; L F Brass
Journal:  J Thromb Haemost       Date:  2003-07       Impact factor: 5.824

4.  Expression of junctional proteins in human platelets.

Authors:  J W Elrod; J H Park; T Oshima; C D Sharp; A Minagar; J S Alexander
Journal:  Platelets       Date:  2003-06       Impact factor: 3.862

5.  Identification of the platelet ADP receptor targeted by antithrombotic drugs.

Authors:  G Hollopeter; H M Jantzen; D Vincent; G Li; L England; V Ramakrishnan; R B Yang; P Nurden; A Nurden; D Julius; P B Conley
Journal:  Nature       Date:  2001-01-11       Impact factor: 49.962

6.  PECAM-1 (CD31) expression modulates bleeding time in vivo.

Authors:  S Mahooti; D Graesser; S Patil; P Newman; G Duncan; T Mak; J A Madri
Journal:  Am J Pathol       Date:  2000-07       Impact factor: 4.307

7.  E-cadherin is a survival factor for the lactating mouse mammary gland.

Authors:  Oréda Boussadia; Stefanie Kutsch; Andreas Hierholzer; Véronique Delmas; Rolf Kemler
Journal:  Mech Dev       Date:  2002-07       Impact factor: 1.882

8.  Real-time in vivo imaging of platelets, tissue factor and fibrin during arterial thrombus formation in the mouse.

Authors:  Shahrokh Falati; Peter Gross; Glenn Merrill-Skoloff; Barbara C Furie; Bruce Furie
Journal:  Nat Med       Date:  2002-09-16       Impact factor: 53.440

9.  Transgenic mice studies demonstrate a role for platelet factor 4 in thrombosis: dissociation between anticoagulant and antithrombotic effect of heparin.

Authors:  Don E Eslin; Chunyan Zhang; Kathleen J Samuels; Lubica Rauova; Li Zhai; Stefan Niewiarowski; Douglas B Cines; Mortimer Poncz; M Anna Kowalska
Journal:  Blood       Date:  2004-02-05       Impact factor: 22.113

10.  Defects in secretion, aggregation, and thrombus formation in platelets from mice lacking Akt2.

Authors:  Donna Woulfe; Hong Jiang; Alicia Morgans; Robert Monks; Morris Birnbaum; Lawrence F Brass
Journal:  J Clin Invest       Date:  2004-02       Impact factor: 14.808

View more
  3 in total

1.  Murine cadherin-6 mediates thrombosis in vivo in a platelet-independent manner.

Authors:  Emma G Bouck; Maria de la Fuente; Elizabeth R Zunica; Wei Li; Michele M Mumaw; Marvin T Nieman
Journal:  Res Pract Thromb Haemost       Date:  2020-12-04

Review 2.  Modulation of Immune Responses by Platelet-Derived ADAM10.

Authors:  Stefanie Maurer; Hans-Georg Kopp; Helmut R Salih; Korbinian N Kropp
Journal:  Front Immunol       Date:  2020-02-05       Impact factor: 7.561

3.  The Missing Protein: Is T-Cadherin a Previously Unknown GPI-Anchored Receptor on Platelets?

Authors:  Maria N Balatskaya; Alexandra I Baglay; Alexander V Balatskiy
Journal:  Membranes (Basel)       Date:  2021-03-19
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.